RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma
- 28 April 2022
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 538, 215711
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (21ZR1409400)
- National Natural Science Foundation of China (81790252, 81872233, 81930123, 82121004)
This publication has 45 references indexed in Scilit:
- Proteome-Wide Characterization of the RNA-Binding Protein RALY-Interactome Using the in Vivo-Biotinylation-Pulldown-Quant (iBioPQ) ApproachJournal of Proteome Research, 2013
- NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell linesMolecular Cancer, 2011
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progressionJournal of Clinical Investigation, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedGenes & Development, 2010
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancerNature, 2009
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approachesNature Reviews Molecular Cell Biology, 2009
- Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNANature Chemical Biology, 2007
- A positive feedback loop couples Ras activation and CD44 alternative splicingGenes & Development, 2006
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994